RdB/IL-12/IL-18 also increases the cytokine ratio of Th1/Th2, increases tumor infiltration of CD4+ T, CD8+ T and NK cells, and promotes differentiation of T cells expressing IL-12Rβ2 or IL-18Rα [46]. Here, CD4 is linked to neoplasm.